Sequences for detection and identification of methicillin-resistant Staphylococcus aureus (MRSA)
First Claim
1. A method of detecting the presence of a methicillin-resistant Staphylococcus aureus (MRSA) strain in a sample comprising nucleic acids, wherein the MRSA strain comprises an SCCmec insert comprising a mecA gene inserted in bacterial nucleic acids, and wherein the insertion of said SSCmec insert in the bacterial nucleic acids generates a polymorphic right extremity junction (MREJ), said method comprising:
- providing at least one primer and/or probe that is specific for MRSA strains, wherein the primer and/or probe anneals to at least one polymorphic MREJ nucleic acid of types xi to xx;
annealing the nucleic acids of the sample with the primer(s) and/or probe(s), wherein annealed primer(s) and/or probe(s) indicate the presence of an MRSA strain in the sample; and
detecting the presence and/or amount of annealed probe(s), or detecting the amount of an amplification product produced through annealing of the primers to the nucleic acids, as an indication of the presence and/or amount of MRSA.
1 Assignment
0 Petitions
Accused Products
Abstract
Described herein are novel SCCmec right extremity junction (MREJ) sequences for the detection and/or identification of methicillin-resistant Staphylococcus aureus (MRSA). Disclosed are methods and compositions based on DNA sequences for the specific detection of MREJ sequences designated types xi, xii, xiii, xiv, xv, xvi, xvii, xviii, xix, and xx for diagnostic purposes and/or epidemiological typing.
-
Citations
53 Claims
-
1. A method of detecting the presence of a methicillin-resistant Staphylococcus aureus (MRSA) strain in a sample comprising nucleic acids, wherein the MRSA strain comprises an SCCmec insert comprising a mecA gene inserted in bacterial nucleic acids, and wherein the insertion of said SSCmec insert in the bacterial nucleic acids generates a polymorphic right extremity junction (MREJ), said method comprising:
-
providing at least one primer and/or probe that is specific for MRSA strains, wherein the primer and/or probe anneals to at least one polymorphic MREJ nucleic acid of types xi to xx;
annealing the nucleic acids of the sample with the primer(s) and/or probe(s), wherein annealed primer(s) and/or probe(s) indicate the presence of an MRSA strain in the sample; and
detecting the presence and/or amount of annealed probe(s), or detecting the amount of an amplification product produced through annealing of the primers to the nucleic acids, as an indication of the presence and/or amount of MRSA. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 23, 24, 25, 26, 27, 28, 29, 30, 31, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 50, 51, 52, 53)
-
-
22. The method of claim I 1, wherein the plurality of primers and/or probes further comprises the primers and/or probes of SEQ ID NOs:
- 34, 44, 45, 52, and 62 for the detection of MREJ type xii.
- View Dependent Claims (32)
-
46. A nucleic acid selected from the group consisting of:
-
SEQ ID NOs;
17, 18, 19 (MREJ type xi);
SEQ ID NO;
20 (MREJ type xii);
SEQ ID NOs;
15, 25, 26 (MREJ type xiii);
SEQ ID NO;
16 (MREJ type xiv);
SEQ ID NO;
56 (MREJ type xv);
SEQ ID NO;
21 (MREJ type xvi);
SEQ ID NO;
55 (MREJ type xvii);
SEQ ID NOs;
39, 40 (MREJ type xviii);
SEQ ID NO;
41 (MREJ type xix); and
SEQ ID NO;
42 (MREJ type xx), or the complement thereof. - View Dependent Claims (47)
-
-
48. An oligonucleotide pair selected from the group consisting of:
-
oligonucleotides comprising the sequences of SEQ ID NOs;
34/45, 34/30, 34/76, and 34/44, for the detection of MREJ type xi,oligonucleotides comprising the sequences of SEQ ID NOs;
35/45, 35/30, 35/62, and 35/44 for the detection of MREJ type xii,oligonucleotides comprising the sequences of SEQ ID NOs;
29/45, 29/30, 29/76, and 29/44 for the detection of MREJ type xiii,oligonucleotides comprising the sequences of SEQ ID NOs;
29/45, 29/30, 29/59, and 29/44 for the detection of MREJ type xiv,oligonucleotides comprising the sequences of SEQ ID NOs;
24/45, 24/30, 24/62, and 24/44 for the detection of MREJ type xv,oligonucleotides comprising the sequences of SEQ ID NOs;
36/44 for the detection of MREJ type xvi,oligonucleotides comprising the sequences of SEQ ID NOs;
4/45, 430, 4/62, and 4/44 for the detection of MREJ type xvii,oligonucleotides comprising the sequences of SEQ ID NOs;
7/45, 7/30, 7/59, and 7/44 for the detection of MREJ type xviii,oligonucleotides comprising the sequences of SEQ ID NOs;
9/45, 9/30, 9/59, and 9/44 for the detection of MREJ type xix, andoligonucleotides comprising the sequences of SEQ ID NOs;
8/45, 8/30, 8/59, and 8/44 for the detection of MREJ type xx.
-
-
49. An oligonucleotide comprising the sequence of SEQ ID NO:
- 31, 32, or 33.
Specification